New hope for dialysis patients: drug AP301 targets dangerous phosphate levels
NCT ID NCT06933472
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 3 trial tests whether AP301, a drug taken with meals, can safely lower high blood phosphate in people on kidney dialysis. About 264 participants will receive either AP301 or a low-dose version for 8 weeks, then all get AP301 for 24 weeks. The goal is to see if AP301 helps control phosphate levels and improves quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AP301 (a phosphate binder taken orally with meals)
- What this could lead to
- If it works, AP301 could offer a new option to control high blood phosphate in dialysis patients, potentially improving their health and quality of life.
- What could go wrong
- This is a phase 3 trial, but the comparator is a low dose of AP301, not a placebo, which may limit how well we can judge effectiveness. Also, results may not apply to all dialysis patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE WITH HYPERPHOSPHATEMIA ON MAINTENANCE DIALYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Tsinghua Chang Gung Hospital
RECRUITINGBeijing, Beijing Municipality, 102218, China
-
Central South University-The Third Xiangya Hospital
RECRUITINGChangsha, Hunan, 410013, China
-
Children's Hospital of Fudan University
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200080, China
-
Dallas Renal Group - Dallas
RECRUITINGDallas, Texas, 75237, United States
-
Fudan University-Huashan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Fudan University-Zhongshan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200032, China
-
Gamma Medical Research
RECRUITINGMcAllen, Texas, 78503, United States
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, Henan, 450003, China
-
High Desert Nephrology Association - US Renal Care
RECRUITINGGallup, New Mexico, 87301, United States
-
Huazhong University of Science and Technology-Tongji Medical College - Wuhan Union Hospital
RECRUITINGWuhan, Hubei, 430022, China
-
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
RECRUITINGNanjing, Jiangsu, 210029, China
-
Jiangxi Provincial People's Hospital
RECRUITINGNanchang, Jiangxi, 330006, China
-
NY Kidney & Hypertension Medicine
RECRUITINGRidgewood, New York, 11385, United States
-
Nanjing Medical University-Wuxi People's Hospital (Wuxi No.1 People's Hospital)
RECRUITINGWuxi, Jiangsu, 214023, China
-
Nantong University-Affiliated Hospital
RECRUITINGNantong, Jiangsu, 226001, China
-
Nephrology & Hypertension Associates Ltd - Tupelo
RECRUITINGTupelo, Mississippi, 38801, United States
-
Nephrology & Hypertension Specialists
RECRUITINGDalton, Georgia, 30720, United States
-
Nephrology Associates, P.C. - Columbus
RECRUITINGColumbus, Mississippi, 38801, United States
-
North America Research Institute - San Dimas
RECRUITINGSan Dimas, California, 91773, United States
-
North America Research Institute - San Dimas
RECRUITINGSan Dimas, California, 91773, United States
-
PACT Kidney Care - Orange
RECRUITINGOrange, Connecticut, 06477, United States
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100035, China
-
Peking University International Hospital
RECRUITINGBeijing, Beijing Municipality, 102218, China
-
Qingdao University-The Affiliated Hospital
RECRUITINGQingdao, Shandong, 266000, China
-
Renal Associates Of Baton Rouge, LLC
RECRUITINGBaton Rouge, Louisiana, 70808, United States
-
Renal Consultants Medical Group
RECRUITINGGranada Hills, California, 91344, United States
-
Rocky Mountain Kidney Care - Lone Tree
RECRUITINGLone Tree, Colorado, 80124, United States
-
Shanghai Jiao Tong University School of Medicine (SJTUSM)-Renji Hospital
RECRUITINGShanghai, Shanghai Municipality, 200000, China
-
Shanghai Tongren Hospital
RECRUITINGShanghai, Shanghai Municipality, 200336, China
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, 610072, China
-
Southeast University-Zhongda Hospital
RECRUITINGNanjing, Jiangsu, 210009, China
-
Subei People's Hospital
RECRUITINGYangzhou, Jiangsu, 225002, China
-
The First Affiliated Hospital of Xiamen University
RECRUITINGXiamen, Fujian, 361003, China
-
US Renal Care - Alexis
RECRUITINGToledo, Ohio, 43613, United States
-
US Renal Care - Bluebonnet
RECRUITINGFort Worth, Texas, 76110, United States
-
US Renal Care - Fort Myers South
RECRUITINGFort Myers, Florida, 33912, United States
-
US Renal Care - Hill Country
RECRUITINGSan Antonio, Texas, 78251, United States
-
US Renal Care - South San Antonio
RECRUITINGSan Antonio, Texas, 78211, United States
-
US Renal Care - West Cheektowaga
RECRUITINGCheektowaga, New York, 14215, United States
-
Wuhan University People's Hospital
RECRUITINGWuhan, Hubei, 430060, China
-
Yantai Yuhuangding Hospital
RECRUITINGYantai, Shandong, 264099, China
-
Zhengzhou University-First Affiliated Hospital
RECRUITINGZhengzhou, Henan, 450003, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which nerve block offers better pain control for dialysis access surgery?
- Can a single dose of zoledronic acid safely treat bone loss in dialysis patients?
- Could a milk protein help dialysis patients fight anemia?
- Less dialysis, more kidney? study tests gentler start for kidney failure patients
- Heat pack before dialysis needle may ease pain, study tests best timing
- Diabetes drug semaglutide tested in dialysis patients for safety